Abstract

Liver resection is the standard treatment for any liver lesion. Laparoscopic liver resection is associated with lower intra-operative blood loss and fewer complications than open resection. Access to the posterior part of the right liver lobe is very uncomfortable and difficult for surgeons due the anatomic position, especially when employing laparoscopic surgery. Based on these experiences, a new laparoscopic device was developed that is capable of bending its long axis and allowing the application of radiofrequency energy in areas that were not technically accessible. The device is equipped with four telescopic needle electrodes that cause tissue coagulation after the delivery of radiofrequency energy. Ex vivo testing was performed in 2012 and 2014 at the University Hospital, Ostrava, on a porcine liver tissue. The main goal of this testing was to verify if the newly proposed electrode layout was suitable for sufficient tissue coagulation and creating a safety zone around lesions. During the ex vivo testing, the material of needle electrodes was improved to achieve the lowest possibility of adhesion. The power supply was adjusted from 20 to 120 W and the ablation time, which varied from 10 to 110 s, was monitored. Subsequently, optimal power delivery and time for coagulation was determined. This experimental study demonstrated the feasibility and safety of the newly developed device. Based on the ex vivo testing, LARA-K1 can create a safety zone of coagulation. For further assessment of the new device, an in vivo study should be performed.

Highlights

  • Hepatic resection is currently the standard treatment for liver lesions

  • Secondary tumors and metastases in liver are mainly caused by gastrointestinal tumors, most often by colorectal cancer

  • Laparoscopic liver resection is common and an easier liver surgery technique performed in the recent times

Read more

Summary

Introduction

Hepatic resection is currently the standard treatment for liver lesions. The number of liver resections is increasing due to increasing numbers of primary and secondary tumors of liver parenchyma. Based on the above information, a new device was developed, which facilitated access to the posterior segments in the laparoscopic approach. The main purpose of this ex vivo study was to determine if the prototype of the newly developed adjustable device (LARA-K1) is functional and safe. During 2009–2012, a new device was developed, which, after its introduction into the abdominal cavity through a laparoscopic trocar, could bend its long axis and eject the telescopic needles to the required position. This technical arrangement allows the application of radiofrequency energy in areas that are currently inaccessible.

Material and Methods
Discussion
Results

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.